Compounds with immunomodulatory activity and therapeutic uses thereof

US12448359B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12448359-B2
Application numberUS-202117908530-A
CountryUS
Kind codeB2
Filing dateMar 5, 2021
Priority dateMar 11, 2020
Publication dateOct 21, 2025
Grant dateOct 21, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention generally relates to new compounds for therapeutic uses. In particular, the disclosed series compounds with immunomodulatory activities are useful for treatment of dysfunctions of the immune system and various cancers. Pharmaceutical composition matters and methods for treating a patient with an immune disease and/or a cancer by administering therapeutically effective amounts of such compound alone or together with other therapeutics are within the scope of this disclosure.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound having the formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar 1 is 2,3-dihydrobenzo [b] [1,4]-dioxinyl; R 1 and R 2 are each, independently, alkyloxy; R 3 is alkyl; and Q is 2. The compound according to claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 1 and R 2 are each methoxyl. 3. The compound according to claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 3 is CH 3 . 4. The compound according to claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is: 5. A pharmaceutical composition comprising one or more compounds of claim 1 , or a pharmaceutically acceptable salt thereof, together with one or more diluents, excipients or carriers. 6. A method for treating a cancer patient, which method comprises administering a therapeutically effective amount of one or more compounds of claim 1 , or a pharmaceutical composition comprising same and one or more carriers, diluents, or excipients, to the cancer patient. 7. The method according to claim 6 , wherein said cancer is castration-resistant prostate cancer.

Assignees

Inventors

Classifications

  • Organoboranes and organoborohydrides · CPC title

  • containing three or more hetero rings · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • containing three or more hetero rings · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12448359B2 cover?
The present invention generally relates to new compounds for therapeutic uses. In particular, the disclosed series compounds with immunomodulatory activities are useful for treatment of dysfunctions of the immune system and various cancers. Pharmaceutical composition matters and methods for treating a patient with an immune disease and/or a cancer by administering therapeutically effective amou…
Who is the assignee on this patent?
Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification C07D277/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).